O conteúdo desse portal pode ser acessível em Libras usando o VLibras


Oswaldo Cruz Foundation an institution in the service of life

Início do conteúdo

Buscar na Fiocruz

Exibindo 100 de 849 resultados encontrados
Opções avançadas
Data de publicação: 24/05/2022 - 15:57
A study led by the Oswaldo Cruz Institute (IOC/Fiocruz) registered, in images, the step-by-step of the infection process caused by the coronavirus (Sars-CoV-2) in Vero cells, obtained from monkey kidneys and widely used in research to understand pathogen biology and to develop treatments. Published in Viruses magazine, the work shows how the virus invades the cell, identifies the compartments where important steps of viral replication occur, and...
Data de publicação: 24/05/2022 - 11:13
Some solutions found by Fiocruz for certain health issues in Brazil, including during the pandemic, could work as a basis for response in other countries. This was one of the conclusions of a group of representatives of Doctors Without Borders (DWB or MSF, in the acronym in portuguese), who visited the Foundation last monday (May 16). They discussed issues such as production and access to vaccines and medicines, effects of COVID-19 on...
Data de publicação: 20/05/2022 - 17:15
On a six-day trip to Portugal, the president of the Oswaldo Cruz Foundation, Nísia Trindade Lima, was received by 14 Portuguese authorities, including three ministers, two rectors, an ambassador, and directors and presidents of institutions involving health, education, technology, and innovation, to deepen and structure inter-institutional cooperation between Fiocruz and Portuguese organizations. The trip took place between the last week...
Data de publicação: 19/05/2022 - 11:56
Last Thursday (12 May) was the ceremony of donation of equipment to Fiocruz by the Japanese government, destined to the Immunobiological Technology Institute (Bio-Manguinhos) and the Oswaldo Cruz Institute (IOC). The donation is part of a cooperation project between Brazil and Japan to improve the institution’s capacity against COVID-19. On this occasion, delegations from the Japanese consulate, the Japanese International Cooperation...
Data de publicação: 17/05/2022 - 17:10
Half the people diagnosed with COVID-19 present sequelae that may last for more than a year. This is one of the conclusions of a longitudinal study developed at Fiocruz Minas, which evaluated the effects of the disease over time. The research followed, for 14 months, 646 patients who had had the infection, and verified that 324 of them, that is, 50.2%, had post-infection symptoms, characterizing what the World Health Organization (WHO)...
Data de publicação: 13/05/2022 - 16:36
During a visit to Fiocruz last Friday (6 May), the World Health Organization's (WHO) technical lead for COVID-19 response, Maria Van Kerkhove, debated the learnings and challenges necessary to maintain investments that were focused on the pandemic's preparedness for possible new public health emergencies. After getting to know more about the Foundation’s actions and visiting the Laboratory for Measles and Respiratory Viruses of the...
Data de publicação: 13/05/2022 - 14:58
The complex dynamic of public health on Brazil’s borders with other South American countries and with the French Overseas Department of French Guiana is a challenge that must be faced in an increasingly integrated way with the different players that make up the health systems in these areas, on both sides of the international frontier. It was in the attempt to improve this relationship and to plan joint actions that representatives of the...
Data de publicação: 10/05/2022 - 16:00
Beatriz Grinsztejn, infectiologist and head of the Laboratory of Clinical Research in STD and AIDS of the National Institute of Infectiology (INI/Fiocruz), received last Thursday (5/5), the award HIV Vaccine Network Service Award, granted during a 2022 HVTN/CoVPN Full Group Meeting, in Washington, USA. The award was given in recognition of her outstanding contribution to the network. The HIV Vaccine Trials Network (HVTN), based in Seattle, is...
Data de publicação: 09/05/2022 - 15:07
On April 26, Fiocruz received a visit from the director of the Jenner Institute, University of Oxford, Adrian Hill. Within the scope of the Foundation's Deliberative Council, he was given a plaque in gratitude to him and his university team for the development of the Oxford/Astrazeneca vaccine, today produced 100% nationally at the Institute of Technology in Immunobiological (Bio-Manguinhos/ Fiocruz), after technology transfer. Then, the...
Data de publicação: 09/05/2022 - 14:08
Through its Institute of Drug Technology (Farmanguinhos), Fiocruz signed last Tuesday (May 3) an agreement of technological cooperation with American pharmaceutical company MSD (Merck Sharp & Dohme). The goal is to manufacture in Brazil the first oral antiviral drug to treat COVID-19. Last Wednesday (May 4) afternoon, Brazil’s National Agency for Health Surveillance (Anvisa) released the authorization to use the drug in the country on...
Data de publicação: 04/05/2022 - 12:41
Boletim Internacional
Data de publicação: 28/04/2022 - 15:05
“There are many nuclear missiles in the world. Why don’t we have enough plants to produce vaccines?” The demand came from Adrian Hill, director of the Jenner Institute, of the University of Oxford. One of the main developers of the Oxford/AstraZeneca COVID-19 vaccine, Hill attended the Symposium on Emerging and Persisting Global Health Threats, organized by Fiocruz and by the National Institute of Allergy and Infectious...
Data de publicação: 26/04/2022 - 16:04
The Leônidas & Maria Deane Institute (Fiocruz Amazônia), in a partnership with the Tropical Medicine Foundation (FMT), is participating in a pre-clinical trial project for a vaccine against the vivax variety of malaria. The project has just had its sponsoring approved by the Global Health Innovative Technology Fund (GHIT) of Japan. The research is coordinated by researcher Shigeto Yoshida, of the University of Kanazawa, and its...
Data de publicação: 26/04/2022 - 15:15
Fiocruz Ceará will welcome a researcher from Pasteur Institute and begin integrated research works aiming at setting up the Fiocruz-Pasteur Platform at the Oswaldo Cruz Foundation campus in Eusébio, in Fortaleza’s Metropolitan Area, in the state of Ceará. The announcement was made by the representative of the Ministry for Europe and Foreign Affairs of France, Leandro Batista, during the event that gathered scientists...
Data de publicação: 25/04/2022 - 15:40
For the World Chagas Disease Day, celebrated on April 14, Fiocruz organized a series of activities last week. Among the actions are two online events with lectures and debates about the challenges and possibilities to fight the disease. Last Monday, on one of these occasions, the theme series Memorias of the Oswaldo Cruz Institute was launched, with 15 reflection papers by authors from all over the world and from different areas of knowledge...
Data de publicação: 14/04/2022 - 14:16
Last Monday, April 11, was the first day of the international workshop Innovation by Entrepreneurship, promoted by Fiocruz in a partnership with the Pasteur Institute. The purpose of the event, which will continue on Tuesday, April 12, is to present the results of entrepreneurship initiatives of both institutions and to promote a debate between their researchers. Marco Krieger, Fiocruz vice-president of Production and Innovation in Health,...
Data de publicação: 13/04/2022 - 15:05
Delegations from the Danish government and the National Institute of Industrial Property (Inpi) visited Fiocruz last Wednesday (4/6) as part of cooperation activities for innovation in Health between Brazil and the European country. The cooperation relationship is in phase 2, dedicated to the health issue, and, following an invitation from Inpi, Fiocruz has been participating in the project. The Foundation's delegations and representatives...
Data de publicação: 12/04/2022 - 17:58
A new study by Fiocruz, published in Lancet Infectious Diseases last Thursday (March 31), shows that even people with previous infection by Sars-CoV-2 have higher protection levels when vaccinated. The highest effectiveness was observed with the four vaccines in use in Brazil (Coronavac, AstraZeneca, Janssen, and Pfizer-BioNTech) in the prevention of COVID-19. The research shows increased protection against infection and, in particular, against...
Data de publicação: 12/04/2022 - 17:33
Released this Friday (April 4), the Fiocruz COVID-19 Observatory Report shows maintenance of the falling trend of COVID-19 incidence and mortality indicators. The document highlights that for the first time since May 2020, no Brazilian state has exceeded 0.3 deaths per 100,000 inhabitants. The researchers state that according to these new data it is possible to say that the third epidemic wave in Brazil, with a predominance of Omicron among the...
Data de publicação: 12/04/2022 - 12:16
Fiocruz hosted, on March 21st, 2022, a meeting that celebrated the victorious partnership in the field of health surveillance. In November 2021, the city of São José dos Pinhais, in the state of Paraná, received the Guangzhou award along with nine other towns around the world. The award selects innovatives approaches adopted by local and regional governments to reach the Sustainable Development Goals (SDG), thus improving...
Data de publicação: 08/04/2022 - 15:33
Last Tuesday (March 29), Fiocruz and Drugs for Neglected Diseases initiative (DNDi) signed a Memorandum of Understanding for dengue fever research and treatment. The occasion also sealed a Strategic Research Alliance between the two institutions and the joint submission of a project to the Finep Public Call for Neglected Diseases. In addition to signing the Memorandum of Understanding for dengue fever, the occasion sealed a Strategic...
Data de publicação: 04/04/2022 - 12:55
The international partnerships at Fiocruz are governed by various collaborative agreements. The following is a list of the agreements currently in force.  North-South In France, FIOCRUZ is the only Brazilian institution that belongs to the Pasteur World Network, which maintains projects with the Alliance Nationale pour les Sciences de la Vie et la Santé (Aviesan), a French national institution that includes the Institut...
Data de publicação: 04/04/2022 - 12:54
The operational activities pertaining to international exchange feature drafting agreements, contracts, and/or memoranda of understanding with institutions from partner countries, procedures for time spent abroad, orientation on applications for special passports and requests for third party notes, and receiving foreign colleagues at the Foundation. International Agreements These are formal instruments for establishing and strengthening...
Data de publicação: 31/03/2022 - 18:30
The implementation of a World Health Organization (WHO) hub for Pandemic and Epidemic Intelligence led the WHO to organize the visit of a top-level delegation, together with the Pan-American Health Organization (PAHO), to Fiocruz last Thursday (March 24). Led by the assistant director-general of the Division of Intelligence and Surveillance Systems for Emergencies in Health, Chikwe Ihekweazu, who is also the director of the hub, and Socorro...


Back to the topBack